Entry ID,Collection Temperature,Release Date,Resolution,Title
2R69,100,12/25/07,3.8,Crystal structure of Fab 1A1D-2 complexed with E-DIII of Dengue virus at 3.8 angstrom resolution
2QTW,100,9/18/07,1.9,The Crystal Structure of PCSK9 at 1.9 Angstroms Resolution Reveals structural homology to Resistin within the C-terminal domain
2R9P,100,12/11/07,1.4,Human mesotrypsin complexed with bovine pancreatic trypsin inhibitor(BPTI)
2QY0,100,2/5/08,2.6,Active dimeric structure of the catalytic domain of C1r reveals enzyme-product like contacts
2QXJ,100,1/8/08,2.1,Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and Copper
2R9J,300,10/9/07,2.55,Ligand recognition in C-lobe: The crystal structure of the complex of lactoferrin C-lobe with nicotinamide at 2.5 A resolution
2QXI,100,1/8/08,1,High resolution structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone
2QXH,100,1/8/08,2,Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone
2QXG,100,1/8/08,2.6,Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone
2QYI,100,8/19/08,2.6,Crystal structure of a binary complex between an engineered trypsin inhibitor and Bovine trypsin
2RA3,100,12/11/07,1.46,Human cationic trypsin complexed with bovine pancreatic trypsin inhibitor (BPTI)
2RA0,200,1/29/08,2.3,X-ray Structure of FXa in complex with 7-fluoroindazole
2RCE,100,12/11/07,2.35,DFP modified DegS delta PDZ
2RG3,100,7/1/08,1.8,Covalent complex structure of elastase
2SGF,287,8/26/03,1.75,PHE 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
2SGQ,287,8/26/03,1.8,GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
2SGP,287,1/31/01,1.8,PRO 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
2TIO,293,9/30/98,1.93,LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE
2STB,293,1/19/00,1.8,ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)
2STA,293,1/19/00,1.8,ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I)
2SGE,287,8/26/03,1.8,GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7
2SGD,287,8/26/03,1.8,ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7
2THF,100,3/7/99,2.1,STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE
2SNW,285,4/8/98,2.7,"SINDBIS VIRUS CAPSID PROTEIN, TYPE3 CRYSTAL FORM"
6CYM,100,5/9/18,2.9,Reversible Covalent Direct Thrombin Inhibitors
6DCM,100,5/15/19,1.031,The atomic resolution crystal structure of Kringle 2 variant bound with EACA
6DFI,100,10/24/18,2.48,Crystal structure of anti-Zika antibody Z021 bound to Zika virus envelope protein DIII
6DI8,100,1/23/19,1.859,Crystal structure of bovine alpha-chymotrypsin in space group P65
6DL7,100,5/8/19,2,Human mitochondrial ClpP in complex with ONC201 (TIC10)
6E0U,100,7/10/19,2.75,Staphylococcus pseudintermedius exfoliative toxin EXI
6E4Z,100,4/10/19,2.202,Anti-PCSK9 fab 6E2 bound to the modified N-terminal peptide from PCSK9
6E4Y,100,4/10/19,2.24,"Anti-PCSK9 fab 6E2 bound to the N-terminal peptide from PCSK9, unmodified"
6E5M,100,3/13/19,1.612,Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 32 2 1
6DWF,100,1/30/19,1.94,"Crystal structure of complex of BBKI mutant, L55R with Bovine Trypsin"
6DWH,100,1/30/19,2,Crystal structure of complex of BBKI and Bovine Trypsin
6DWR,100,7/3/19,1.319,Trypsin serine protease modified with the protease inhibitor cyanobenzylsulfonylfluoride
6DWQ,100,7/3/19,1.27,Subtilisin serine protease modified with the protease inhibitor cyanobenzylsulfonylfluoride
6DWU,100,1/30/19,3.96,Crystal structure of complex of BBKI and Bovine Trypsin
6DZF,100,9/19/18,2.2,Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant
6EAU,100,8/7/19,1.18,Crystallographic structure of the octapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21.
6EAT,100,3/13/19,1.149,Crystallographic structure of the cyclic nonapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21.
6EAW,100,8/7/19,1.289,Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21
6EAV,100,8/7/19,1.391,Crystallographic structure of the cyclic heptapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 4(1) 2(1) 2
6EAX,100,8/7/19,1.189,Crystallographic structure of the cyclic hexapeptide derived from the BTCI inhibitor bound to beta-trypsin in space group P 21 21 21
6EO9,100,12/13/17,1.84,Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor
6EO8,77,12/13/17,1.94,Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor
6EO7,100,10/18/17,2.24,X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(acetamide-N-yl)-1-propen-1-yl)-2'-deoxyuridine residue
6EO6,100,10/25/17,1.69,X-ray structure of the complex between human alpha-thrombin and modified 15-mer DNA aptamer containing 5-(3-(2-(1H-indol-3-yl)acetamide-N-yl)-1-propen-1-yl)-2'-deoxyuridine residue
6EPK,100,10/31/18,2.7,CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS
6F1D,100,1/17/18,1.95,CUB2 domain of C1r
6F1C,100,1/17/18,4.2,C1rC1s complex
6F1H,100,1/17/18,4.5,C1rC1s complex
6EQW,100,2/28/18,1.994,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor 4-aminomethyl-phenylacetyl-Arg-Val-Arg-Amba
6EQV,100,2/28/18,1.895,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Phac-Cit-Val-Arg-Amba
6EQX,100,2/28/18,1.994,X-ray structure of the proprotein convertase furin bound with the competitive inhibitor Arg-Arg-Arg-Val-Arg-Amba
6F39,100,1/24/18,5.801,C1r homodimer CUB1-EGF-CUB2
6F5M,100,8/8/18,2.7,Crystal structure of highly glycosylated human leukocyte elastase in complex with a thiazolidinedione inhibitor
6F5G,100,2/6/19,2.196,Complete PCSK9 C-ter domain in complex with VHH P.140
6EW9,100,4/25/18,2.2,CRYSTAL STRUCTURE OF DEGS STRESS SENSOR PROTEASE IN COMPLEX WITH ACTIVATING DNRLGLVYQF PEPTIDE
6EVV,100,10/24/18,2.5,"X-ray structure of the complex between human alpha thrombin and NU172, a duplex/quadruplex 26-mer DNA aptamer, in the presence of potassium ions."
6VJB,100,4/15/20,2.24,Crystal structure of a catalytically inactive CXC Chemokine-degrading protease SpyCEP from Streptococcus pyogenes
6VJ9,100,9/16/20,2.3,Crystal structure of GlpG in complex with peptide boronate inhibitor
6VJ8,100,9/16/20,2.3,Crystal structure of GlpG in complex with peptide chloromethylketone inhibitor
6VMJ,100,2/3/21,2.95,Crystal structure of human Complement Factor D with anti-Factor D Fab 20D12
6VMK,100,2/3/21,3.01,Crystal structure of human Complement Factor D with anti-Factor D Fab 20D12
6VLU,100,5/6/20,1.6,Factor XIa in complex with compound 7
6VLV,100,5/6/20,1.72,Factor XIa in complex with compound 11
6VSO,100,7/15/20,3.001,DengueV-2 Capsid Structure
6W50,100,6/10/20,1.95,"FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((10R,14S)- 14-(4-(3-CHLORO-2,6-DIFLUOROPHENYL)-6-OXO-3,6-DIHYDRO- 1(2H)-PYRIDINYL)-10-METHYL-9-OXO-8,16- DIAZATRICYCLO[13.3.1.0~2,7~]NONADECA-1(19),2,4,6,15,17- HEXAEN-5-YL)CARBAMATE"
6W4G,100,11/4/20,1.95,Hepatitis C virus polymerase NS5B with RO inhibitor for SAR studies
6VTM,100,4/22/20,1.6,Human Cathepsin-G Inhibited by S. aureus EapH1
6UYD,100,4/22/20,1.897,Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C
6UYG,100,4/22/20,3.375,Structure of Hepatitis C Virus Envelope Glycoprotein E2c3 core from genotype 6a bound to broadly neutralizing antibody AR3A and non neutralizing antibody E1
6UYF,100,4/22/20,2.06,Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B
6VDM,100,12/30/20,1.9,"HCV NS3/4A protease A156T, D168E double mutant in complex with glecaprevir"
6VDL,100,12/30/20,1.95,HCV NS3/4A protease A156T mutant in complex with glecaprevir
6VDO,100,12/30/20,2.11,"HCV NS3/4A protease A156T, D168E double mutant"
6VDN,100,12/30/20,2.15,HCV NS3/4A protease A156T mutant
6VG5,100,7/15/20,1.5,DengueV-2 Capsid ST148 inhibitor Complex
6VVU,93,12/30/20,3,Anti-Tryptase fab E104.v1 bound to tryptase
6W9T,100,12/9/20,1.64,Crystal structure of Neisseria meningitidis ClpP protease complex with small molecule activator ACP1-06
6VXY,100,7/1/20,1.398,Triazole bridged SFTI1 inhibitor in complex with beta-trypsin
2OIN,100,6/5/07,2.5,crystal structure of HCV NS3-4A R155K muntant
2OK5,100,2/27/07,2.3,Human Complement factor B
2OLG,100,2/6/07,1.7,Crystal structure of the serine protease domain of prophenoloxidase activating factor-I in a zymogen form
2P1D,100,3/20/07,2.9,Crystal structure of dengue methyltransferase in complex with GTP and S-Adenosyl-L-homocysteine
2P16,100,10/16/07,2.3,"Factor Xa in Complex with the Inhibitor APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE"
2OQ5,298,4/10/07,1.61,"Crystal structure of DESC1, a new member of the type II transmembrane serine proteinases family"
2P1S,292,4/17/07,1.93,Crystal structure of the C-terminal lobe of bovine lactoferrin complexed with O-alpha-D-Glucopyranosyl-(1 3)-alpha-D-fructofuranosyl- (2 1)- alpha-D-glucopyranoside at 1.93 A resolution
2P3L,100,8/28/07,2.2,Crystal Structure of Dengue Methyltransferase in Complex with GpppA and S-Adenosyl-L-Homocysteine
2P3F,100,11/6/07,3.1,Crystal structure of the factor Xa/NAP5 complex
2P3T,100,1/22/08,1.92,Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide
2P3Q,100,8/28/07,2.75,Crystal Structure of Dengue Methyltransferase in Complex with GpppG and S-Adenosyl-L-homocysteine
2P41,100,8/28/07,1.801,Crystal Structure of Dengue Methyltransferase in Complex with 7MeGpppG2'OMe and S-Adenosyl-L-homocysteine
2P3O,100,8/28/07,2.756,Crystal Structure of Dengue Methyltransferase in Complex with 7MeGpppA and S-Adenosyl-L-homocysteine
2P40,100,8/28/07,2.701,Crystal Structure of Dengue Methyltransferase in Complex with 7MeGpppG
2OQU,110,5/1/07,1.8,High Pressure Cryocooling of Capillary Sample Cryoprotection and Diffraction Phasing at Long Wavelengths
2P3W,100,11/6/07,1.7,Crystal Structure of the HtrA3 PDZ Domain Bound to a Phage-Derived Ligand (FGRWV)
2P3U,100,9/11/07,1.62,Crystal structure of human factor XA complexed with 3-chloro-N-(4-chloro-2-{[(5-chloropyridin-2-yl)amino]carbonyl}-6-methoxyphenyl)-4-[(1-methyl-1H-imidazol-2-yl)methyl]thiophene-2-carboxamide {Pfizer 320663}
2P4E,100,4/10/07,1.98,Crystal Structure of PCSK9
2OTV,292,2/27/07,1.56,Crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 A resolution
2P5P,100,3/18/08,2.8,Crystal Structure Analysis of the West Nile virus envelope (E) protein domain III
2P8O,77.2,5/8/07,1.5,Crystal Structure of a Benzohydroxamic Acid/Vanadate complex bound to chymotrypsin A
2P95,100,7/24/07,2.2,"Factor xa in complex with the inhibitor 5-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-YL)benzamido) cyclopentyl)thiophene-2-carboxamide"
2P94,100,7/24/07,1.8,"Factor xa in complex with the inhibitor 3-chloro-N-((1R,2S)-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)cyclohexyl)-1H-indole-6-carboxamide"
2P93,100,7/24/07,1.9,Factor xa in complex with the inhibitor 5-chloro-N-(2-(4-(2-oxopyridin-1(2H)-yl)benzamido)ethyl)thiophene-2-carboxamide
2OY0,100,4/3/07,2.8,Crystal structure of the West Nile virus methyltransferase
2OXT,100,5/15/07,2.9,Crystal structure of Meaban virus nucleoside-2'-O-methyltransferase
2OXS,300,3/13/07,1.32,Crystal Structure of the trypsin complex with benzamidine at high temperature (35 C)
2PKS,100,4/22/08,2.5,Thrombin in complex with inhibitor
2PLX,100,8/7/07,1.56,Trypsin complexed to a synthetic peptide from Veronica hederifolia
2PNM,100,6/5/07,2.3,Crystal Structure of VP4 protease from infectious pancreatic necrosis virus (IPNV) in space group P6122
2PNL,100,6/5/07,2.21,Crystal structure of VP4 protease from infectious pancreatic necrosis virus (IPNV) in space group P1
2PMS,100,6/19/07,2.91,Crystal structure of the complex of human lactoferrin N-lobe and lactoferrin-binding domain of pneumococcal surface protein A
2PMW,100,5/8/07,2.3,The Crystal Structure of Proprotein convertase subtilisin kexin type 9 (PCSK9)
2PQ2,298,5/29/07,1.82,Structure of serine proteinase K complex with a highly flexible hydrophobic peptide at 1.8A resolution
2Q1J,100,8/14/07,1.9,The discovery of glycine and related amino acid-based factor xa inhibitors
2PR3,100,8/14/07,1.5,Factor XA inhibitor
2PRO,100,4/27/99,3,PRO REGION OF ALPHA-LYTIC PROTEASE
2PSY,100,9/11/07,2.3,Crystal Structure of Human Kallikrein 5 in complex with Leupeptin and Zinc
2PSX,100,9/11/07,2.3,Crystal Structure of Human Kallikrein 5 in complex with Leupeptin
2PUQ,100,5/22/07,2.05,Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor
2Q5Y,100,10/14/08,2.3,Crystal Structure of the C-terminal domain of hNup98
2Q5X,100,10/14/08,1.9,Crystal Structure of the C-terminal domain of hNup98
2PW8,100,8/21/07,1.84,Crystal structure of sulfo-hirudin complexed to thrombin
2PUX,100,7/10/07,2,Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR3
2PV9,100,7/10/07,3.5,Crystal structure of murine thrombin in complex with the extracellular fragment of murine PAR4
2PX1,273,5/29/07,2.5,crystal structure of the complex of bovine lactoferrin C-lobe with Ribose at 2.5 A resolution
2Q8J,298,6/19/07,2.71,Crystal Structure of the complex of C-lobe of bovine lactoferrin with Mannitol and Mannose at 2.7 A resolution
2PX8,100,5/29/07,2.2,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAH and 7M-GTP
2PGB,100,7/17/07,1.54,Inhibitor-free human thrombin mutant C191A-C220A
2PHB,100,3/25/08,2.3,An Orally Efficacious Factor Xa Inhibitor
2PGQ,100,7/17/07,1.8,Human thrombin mutant C191A-C220A in complex with the inhibitor PPACK
2PX5,100,5/29/07,2.3,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAH (Orthorhombic crystal form)
2PX4,100,5/29/07,2.2,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAH (Monoclinic form 2)
2PX2,100,5/29/07,2,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAH (Monoclinic form 1)
2PWB,291,5/22/07,1.9,Crystal structure of the complex of proteinase K with coumarin at 1.9 A resolution
2PWA,277,5/29/07,0.83,Crystal Structure of the complex of Proteinase K with Alanine Boronic acid at 0.83A resolution
2PXA,100,5/29/07,2.3,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAH and GTPG
2PXC,100,5/29/07,2.8,Crystal structure of the Murray Valley Encephalitis Virus NS5 2'-O Methyltransferase domain in complex with SAM and GTPA
2PYZ,291,7/3/07,1.79,Crystal structure of the complex of proteinase K with auramine at 1.8A resolution
2PZD,100,8/7/07,2.75,Crystal Structure of the HtrA2/Omi PDZ Domain Bound to a Phage-Derived Ligand (WTMFWV)
2QE5,100,10/2/07,2.6,Structure of HCV NS5B Bound to an Anthranilic Acid Inhibitor
2QE2,100,10/2/07,2.9,Structure of HCV NS5B Bound to an Anthranilic Acid Inhibitor
2QF3,125,12/11/07,2.04,Structure of the delta PDZ truncation of the DegS protease
2QEQ,100,8/14/07,3.1,Crystal structure of kunjin virus ns3 helicase
2QF0,93,12/11/07,2.5,Structure of the delta PDZ truncation of the DegS protease
2QGR,123,12/11/07,2.7,Structure of the R178A mutant of delta PDZ DegS protease
2QJE,298,6/24/08,2.3,Crystal structure of the complex of Bovine C-lobe with Amygdalin at 2.3A resolution
2QN5,100,7/22/08,3,Crystal Structure and Functional Study of the Bowman-Birk Inhibitor from Rice Bran in Complex with Bovine Trypsin
2QOM,100,11/13/07,2.66,The crystal structure of the E.coli EspP autotransporter Beta-domain.
2R0L,100,12/25/07,2.2,Short Form HGFA with Inhibitory Fab75
2R0K,100,12/25/07,3.51,Protease domain of HGFA with inhibitor Fab58
2R18,100,2/5/08,2.3,Structural insights into the multifunctional protein VP3 of Birnaviruses
2R29,100,12/25/07,3,Neutralization of dengue virus by a serotype cross-reactive antibody elucidated by cryoelectron microscopy and x-ray crystallography
2R2W,298,10/23/07,2.01,Urokinase plasminogen activator B-chain-GPPE complex
2R3Y,100,11/27/07,2.5,Crystal structure of the DegS protease in complex with the YWF activating peptide
2R3U,100,11/27/07,2.6,Crystal structure of the PDZ deletion mutant of DegS
6ZUN,100,8/26/20,1.793,Crystal Structure of Thrombin in complex with compound20a
6ZUH,100,8/26/20,1.7,Crystal Structure of Thrombin in complex with compound17
6ZUG,100,8/26/20,1.8,Crystal Structure of Thrombin in complex with compound10
6ZV7,100,8/26/20,1.94,Crystal Structure of Thrombin in complex with compound42b
6ZUU,100,10/7/20,1.94,Crystal structure of Thrombin in complex with compound30
6ZUX,100,8/26/20,1.94,Crystal Structure of Thrombin in complex with compound42a
6ZUW,100,8/26/20,2,Crystal Structure of Thrombin in complex with compound40
6ZV8,100,8/26/20,1.7,Crystal Structure of Thrombin in complex with compound51
7A0E,100,3/17/21,1.9,The Crystal Structure of Bovine Thrombin in complex with Hirudin (C6U/C14U) at 1.9 Angstroms Resolution
7A0D,100,3/17/21,1.6,The Crystal Structure of Bovine Thrombin in complex with Hirudin (C16U/C28U) at 1.6 Angstroms Resolution
7A0F,100,3/17/21,2.7,The Crystal Structure of Bovine Thrombin in complex with Hirudin (C22U/C39U) at 2.7 Angstroms Resolution
7A68,100,10/21/20,2.55,proteinase K crystallized from 0.5 M NaNO3
6ZFK,100,1/13/21,1.1,Trypsin inhibitor in complex with bovine trypsin
6ZFJ,100,1/13/21,1,Trypsin inhibitor in complex with bovine trypsin
6ZGO,100,6/30/21,1.79,Thrombin in complex with D-Phe-Pro-2-chlorofuran derivative (13l)
6ZOV,100,10/21/20,2.19,ENTEROPEPTIDASE IN COMPLEX WITH COMPOUND 6
6ZQ2,100,7/21/21,1.29,Cationic trypsin in complex with a derivative of benzamidine
1D9I,143,10/30/00,2.3,STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1
1DBI,110,11/18/99,1.8,CRYSTAL STRUCTURE OF A THERMOSTABLE SERINE PROTEASE
1DDJ,100,2/18/00,2,CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN
1DE7,93,12/13/00,2,INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX
1DFP,293,2/25/98,2.4,FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE
1DIC,293,7/22/99,1.8,"STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR D"
1DLK,293,5/3/00,2.14,CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR
1DM4,123,1/19/00,2.5,SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16)
1DLE,95,12/13/00,2.1,FACTOR B SERINE PROTEASE DOMAIN
1DOJ,100,11/3/00,1.7,Crystal structure of human alpha-thrombin*RWJ-51438 complex at 1.7 A
1E0F,289,11/3/00,3.1,Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor
1DPO,120,7/7/97,1.59,STRUCTURE OF RAT TRYPSIN
1DS2,298,1/31/01,1.7,CRYSTAL STRUCTURE OF SGPB:OMTKY3-COO-LEU18I
1DST,295,7/11/96,2,MUTANT OF FACTOR D WITH ENHANCED CATALYTIC ACTIVITY
1DT2,100,1/21/03,2.8,CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B
1E5T,100,10/1/00,1.7,"PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT"
1DUA,293,1/21/03,2,CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A
1DTZ,293,6/20/01,2.65,STRUCTURE OF CAMEL APO-LACTOFERRIN DEMONSTRATES ITS DUAL ROLE IN SEQUESTERING AND TRANSPORTING FERRIC IONS SIMULTANEOUSLY:CRYSTAL STRUCTURE OF CAMEL APO-LACTOFERRIN AT 2.6A RESOLUTION.
1DVA,110,5/12/00,3,Crystal Structure of the Complex Between the Peptide Exosite Inhibitor E-76 and Coagulation Factor VIIA
1DUI,100,1/28/00,2,"Subtilisin BPN' from Bacillus amyloliquefaciens, crystal growth mutant"
1DUE,289,1/21/03,2,CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A S195A MUTANT
1DX5,100,4/10/00,2.3,Crystal structure of the thrombin-thrombomodulin complex
1E8N,100,1/16/01,1.5,"PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH PEPTIDE"
1E8M,100,1/16/01,1.5,"PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH INHIBITOR"
1DY9,100,1/28/01,2.1,Inhibition of the Hepatitis C Virus NS3/4A Protease. The Crystal Structures of Two Protease-Inhibitor Complexes (inhibitor I)
1DY8,100,1/28/01,2.4,Inhibition of the Hepatitis C Virus NS3/4A Protease. The Crystal Structures of Two Protease-Inhibitor Complexes (inhibitor II)
1DXP,100,1/12/01,2.4,Inhibition of the Hepatitis C Virus NS3/4A Protease. The Crystal Structures of Two Protease-Inhibitor Complexes (apo structure)
1EAI,287,4/5/99,2.4,COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE
1EB2,100,2/11/02,2,Trypsin inhibitor complex (BPO)
1EB1,100,1/28/02,1.8,Complex structure of human thrombin with N-methyl-arginine inhibitor
1EAX,100,1/28/02,1.3,Crystal structure of MTSP1 (matriptase)
1EAW,100,1/28/02,2.93,Crystal structure of the MTSP1 (matriptase)-BPTI (aprotinin) complex
1EDM,293,10/14/96,1.5,EPIDERMAL GROWTH FACTOR-LIKE DOMAIN FROM HUMAN FACTOR IX
1EH3,113,3/1/00,2,R210K N-TERMINAL LOBE HUMAN LACTOFERRIN
1EGQ,285,2/21/01,1.55,ENHANCEMENT OF ENZYME ACTIVITY THROUGH THREE-PHASE PARTITIONING: CRYSTAL STRUCTURE OF A MODIFIED SERINE PROTEINASE AT 1.5 A RESOLUTION
1EJM,120,3/3/01,1.85,CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN
1EJN,298,5/17/00,1.8,UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX
1EJA,277,3/2/01,2.7,"STRUCTURE OF PORCINE TRYPSIN COMPLEXED WITH BDELLASTASIN, AN ANTISTASIN-TYPE INHIBITOR"
1EKB,100,10/14/99,2.3,THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL-ASP-ASP-ASP-ASP-LYS-CHLOROMETHANE
1ELV,100,3/14/01,1.7,CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE
1F0R,95,9/20/00,2.1,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
1EOL,298,5/3/00,2.1,Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures
1EP6,100,7/8/03,2.45,CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN
1F0U,292,9/20/00,1.9,BOVINE TRYPSIN COMPLEXED WITH RPR128515
1EP5,100,7/8/03,2.3,CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN
1F0T,292,9/20/00,1.8,BOVINE TRYPSIN COMPLEXED WITH RPR131247
1F0S,95,9/20/00,2.1,Crystal Structure of Human Coagulation Factor XA Complexed with RPR208707
1EOJ,298,5/3/00,2.1,Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures
1EQ9,293,10/3/00,1.7,CRYSTAL STRUCTURE OF FIRE ANT CHYMOTRYPSIN COMPLEXED TO PMSF
1F2S,297,6/5/00,1.79,"CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION"
1F5R,277,7/4/01,1.65,RAT TRYPSINOGEN MUTANT COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1F5L,298,6/15/01,2.1,UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-AMILORIDE COMPLEX
1F5K,298,6/15/01,1.8,UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX
1EUF,295,4/14/01,2.4,"BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE"
1F7Z,277,7/4/01,1.55,RAT TRYPSINOGEN K15A COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1F9B,283,2/10/01,2.7,MELANIN PROTEIN INTERACTION: X-RAY STRUCTURE OF THE COMPLEX OF MARE LACTOFERRIN WITH MELANIN MONOMERS
1EX3,100,5/17/00,3,CRYSTAL STRUCTURE OF BOVINE CHYMOTRYPSINOGEN A (TETRAGONAL)
1F92,298,7/6/01,2.6,UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX
1EXF,293,2/25/98,2.1,EXFOLIATIVE TOXIN A
1EZX,100,10/25/00,2.6,CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
1EZU,298,6/23/00,2.4,"ECOTIN Y69F, D70P BOUND TO D102N TRYPSIN"
1EZS,298,6/23/00,2.3,"CRYSTAL STRUCTURE OF ECOTIN MUTANT M84R, W67A, G68A, Y69A, D70A BOUND TO RAT ANIONIC TRYPSIN II"
1EZQ,95,9/20/00,2.2,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515
1FAK,100,12/3/99,2.1,HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
1FCK,283,1/17/01,2.2,STRUCTURE OF DICERIC HUMAN LACTOFERRIN
1FCF,102,1/18/01,2.1,PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE
1FC9,90,1/18/01,1.9,PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE
1FC7,90,1/18/01,2,PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE
1FC6,102,1/18/01,1.8,PHOTOSYSTEM II D1 C-TERMINAL PROCESSING PROTEASE
1FDP,95,12/3/99,2.1,"PROENZYME OF HUMAN COMPLEMENT FACTOR D, RECOMBINANT PROFACTOR D"
7M1V,100,4/21/21,1.6,Structure of Zika virus NS2b-NS3 protease mutant binding the compound NSC86314 in the super-open conformation
7M1M,100,3/24/21,2.6,Crystal structure of Pseudomonas aeruginosa ClpP1
7M1L,100,3/24/21,2,Crystal structure of Pseudomonas aeruginosa ClpP2
7NJJ,293,6/16/21,1.65,Proteinase K grown inside HARE serial crystallography chip
7NTU,100,4/28/21,3.1,X-ray structure of the complex between human alpha thrombin and two duplex/quadruplex aptamers: NU172 and HD22_27mer
1A0L,283,3/23/99,3,HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE
1A0J,295,1/13/99,1.7,CRYSTAL STRUCTURE OF A NON-PSYCHROPHILIC TRYPSIN FROM A COLD-ADAPTED FISH SPECIES.
1A0H,273,6/17/98,3.2,THE X-RAY CRYSTAL STRUCTURE OF PPACK-MEIZOTHROMBIN DESF1: KRINGLE/THROMBIN AND CARBOHYDRATE/KRINGLE/THROMBIN INTERACTIONS AND LOCATION OF THE LINKER CHAIN
1A1V,100,1/13/99,2.2,HEPATITIS C VIRUS NS3 HELICASE DOMAIN COMPLEXED WITH SINGLE STRANDED SDNA
1A1R,100,6/17/98,2.5,HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX
1A1Q,100,3/25/98,2.4,HEPATITIS C VIRUS NS3 PROTEINASE
1A3B,100,6/3/98,1.8,COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1
1A2C,287,7/1/98,2.1,Structure of thrombin inhibited by AERUGINOSIN298-A from a BLUE-GREEN ALGA
1A2Q,290,4/29/98,1.8,SUBTILISIN BPN' MUTANT 7186
1A46,298,5/27/98,2.12,THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR
1A3E,100,6/3/98,1.85,COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2
1A4W,298,4/29/98,1.8,CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE
1A5I,290,3/23/99,2.9,CATALYTIC DOMAIN OF VAMPIRE BAT (DESMODUS ROTUNDUS) SALIVA PLASMINOGEN ACTIVATOR IN COMPLEX WITH EGR-CMK (GLU-GLY-ARG CHLOROMETHYL KETONE)
1A5H,280,4/20/99,2.9,CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE
1A5G,273,5/27/98,2.06,HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1A61,298,6/17/98,2.2,THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR
6XRO,100,9/16/20,2.3,"Crystal structure of GlpG in complex with peptide boronate inhibitor, Ac-KRFRSMQYSA-B(OH)2"
6Y3B,100,7/8/20,1.59,Crystal Structure of Unlinked NS2B-NS3 Protease from Zika Virus in Complex with Inhibitor MI-2110
6XRP,100,9/16/20,2.4,"Crystal structure of GlpG in complex with peptide ketoamide inhibitor, Ac-RVWHA-ketoamide-phenylbutyl"
6Y4S,100,5/20/20,2.23,Human kallikrein-related peptidase 7 (KLK7) in the unliganded state
6Y5S,100,6/17/20,0.95,Crystal structure of savinase at cryogenic conditions
6Y5T,297,6/17/20,1.1,Crystal structure of savinase at room temperature
6XVD,100,2/19/20,1.4,Crystal structure of complex of urokinase and a upain-1 variant(W3F) in pH7.4 condition
6Y9H,100,3/31/21,1.48,Thrombin in complex with D-Phe-Pro-m-Trifluoromethylbenzylamide derivative (phe2)
6XYG,295,2/10/21,1.500002334,Femtosecond structure of bovine trypsin at room temperature
6XYK,295,1/27/21,1.500000326,Crystal structure of bovine trypsin at room temperature.
6YB6,100,3/31/21,1.33,"Thrombin in complex with D-Phe-Pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c)"
6YD2,100,2/17/21,1.8,X-ray structure of furin in complex with the canavanine-based inhibitor 4-aminomethyl-phenylacetyl-canavanine-Tle-Arg-Amba
6YD4,100,2/17/21,1.7,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Canavanine-Amba
6YD3,100,2/17/21,2,X-ray structure of furin in complex with the canavanine derived inhibitor 4-guanidinomethyl-phenylacetyl-Canavanine-Tle-Arg-Amba
6YD7,100,2/17/21,1.8,X-ray structure of furin in complex with the canavanine-based inhibitor 4-guanidinomethyl-phenylacetyl-Arg-Tle-Canavanine-Amba
6YDY,113,3/31/21,1.45,Cationic Trypsin in Complex with a D-Phe-Pro-benzylamine derivative
6YHG,100,4/7/21,1.33,Thrombin in complex with D-Phe-Pro-m-methoxybenzylamide derivative (16a)
6YHJ,100,4/14/21,1.44,Thrombin in complex with D-Phe-Pro-2-chlorothiophen derivative (16e)
6YIW,100,12/2/20,0.97,Trypsin inhibitor in complex with bovine trypsin
6YIV,100,12/2/20,0.95,Trypsin inhibitor in complex with bovine trypsin
6YIY,100,12/2/20,1.11,Trypsin inhibitor in complex with bovine trypsin
6YIX,100,12/2/20,1.31,Trypsin inhibitor in complex with bovine trypsin
6YIS,100,12/2/20,1.19,Trypsin inhibitor in complex with bovine trypsin
6YIU,100,12/2/20,1.36,Trypsin inhibitor in complex with bovine trypsin
6YIT,100,12/2/20,1.25,Trypsin inhibitor in complex with bovine trypsin
6YN3,100,4/21/21,1.49,Thrombin in complex with 4-hydroxybenzamide (j89)
6YMP,100,4/21/21,1.42,Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54)
6Z0E,100,5/19/21,2.6,HtrA1 inactive protease domain S328A with CARASIL mutation R274Q
6Z0Y,100,5/19/21,2.2,HtrA1 inactive protease domain S328A with CARASIL mutations D174R R274Q
6Z0X,100,5/19/21,3.1,HtrA1 inactive protease domain S328A with CARASIL mutations D174R R274Q
6YQV,100,4/28/21,1.45,Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94)
6YSJ,100,5/12/21,1.45,Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10)
6YSX,100,5/12/21,1.48,Thrombin in complex with 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide (j80)
6Z6Q,100,3/17/21,1.81,"Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3-ethyl-2-oxoglutarate, and factor X substrate peptide fragment(39mer-4Ser)"
6Z6R,100,3/17/21,2.13,"Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, N-oxalyl-alpha-methylalanine, and factor X substrate peptide fragment(39mer-4Ser)"
6YV6,100,5/12/21,1.36,Crystal Structure of Serine protease SplB N2K/N3Q/S154R from Staphylococcus aureus
6YV5,100,5/12/21,1.1,Crystal Structure of Serine protease SplB N2K/N3Q/S154R from Staphylococcus aureus
6Z8W,100,1/27/21,1.73,"X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (TBA-3G), which contains 1-beta-D-glucopyranosyl residue in the side chain of Thy3 at N3."
6Z8V,100,1/27/21,1.58,"X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (TBA-3L), which contains 1-beta-D-lactopyranosyl residue in the side chain of Thy3 at N3."
6Z8X,100,1/27/21,2.53,"X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (TBA-3Leu), which contains leucyl amide in the side chain of Thy3 at N3."
6YZA,100,12/2/20,1.3,Trypsin inhibitor in complex with bovine trypsin
6YZC,100,12/2/20,1.42,Trypsin inhibitor in complex with bovine trypsin
6YYW,100,3/17/21,2.27,"Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 2-oxoglutarate, and factor X substrate peptide fragment(39mer-4Ser)"
6YYY,100,3/17/21,2.29,"Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 4,4-dimethyl-2-oxoglutarate, and factor X substrate peptide fragment(39mer-4Ser)"
6YYX,100,3/17/21,1.53,"Aspartyl/Asparaginyl beta-hydroxylase (AspH) oxygenase and TPR domains in complex with manganese, 3-methyl-2-oxoglutarate, and factor X substrate peptide fragment(39mer-4Ser)"
1NFY,100,2/25/03,2.1,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095
1NFX,100,2/25/03,2.15,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944
1NFW,100,2/25/03,2.1,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685
1NFU,100,2/25/03,2.05,CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747
1NHV,105,3/18/03,2.9,Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor
1NHU,105,3/18/03,2,Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor
1NKM,100,2/11/03,2.7,Complex structure of HCMV Protease and a peptidomimetic inhibitor
1NKK,100,2/11/03,2.6,COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR
1NJT,100,2/11/03,2.5,COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR
1NJU,100,2/11/03,2.7,Complex structure of HCMV Protease and a peptidomimetic inhibitor
1NL2,110,9/16/03,2.3,BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM AND LYSOPHOSPHOTIDYLSERINE
1NL1,110,9/16/03,1.9,BOVINE PROTHROMBIN FRAGMENT 1 IN COMPLEX WITH CALCIUM ION
1NKX,283,9/2/03,1.9,CRYSTAL STRUCTURE OF A PROTEOLYTICALLY GENERATED FUNCTIONAL MONOFERRIC C-LOBE OF BOVINE LACTOFERRIN AT 1.9A RESOLUTION
1NLU,100,1/20/04,1.3,Pseudomonas sedolisin (serine-carboxyl proteinase) complexed with two molecules of pseudo-iodotyrostatin
1NM6,100,9/2/03,1.8,thrombin in complex with selective macrocyclic inhibitor at 1.8A
1NN6,100,3/4/03,1.75,Human Pro-Chymase
1O0D,295,10/14/03,2.44,Human Thrombin complexed with a d-Phe-Pro-Arg-type Inhibitor and a C-terminal Hirudin derived exo-site inhibitor
1NO9,298,8/26/03,1.9,Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
1NPM,277,3/23/99,2.1,"NEUROPSIN, A SERINE PROTEASE EXPRESSED IN THE LIMBIC SYSTEM OF MOUSE BRAIN"
1O2K,298,5/13/03,1.63,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2J,298,5/13/03,1.65,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2I,298,5/13/03,1.5,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2H,298,5/13/03,1.77,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2G,285,5/13/03,1.58,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2S,298,9/2/03,1.65,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O34,298,9/2/03,1.5,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2R,298,9/2/03,1.45,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O33,298,9/2/03,1.46,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2Q,298,9/2/03,1.5,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O32,298,9/2/03,1.78,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2P,298,5/13/03,1.47,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O31,298,9/2/03,1.66,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2O,298,5/13/03,1.63,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O30,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2N,298,5/13/03,1.5,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2M,298,5/13/03,1.69,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2L,298,5/13/03,1.68,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3L,285,9/2/03,1.4,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3K,298,9/2/03,1.43,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3J,298,9/2/03,1.4,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3I,298,9/2/03,1.51,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3H,298,9/2/03,1.53,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3G,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3F,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3E,298,9/2/03,1.64,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3P,298,9/2/03,1.81,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3O,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3N,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3M,298,9/2/03,1.55,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2Z,298,9/2/03,1.65,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2Y,285,9/2/03,1.45,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2X,285,9/2/03,1.46,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O39,298,9/2/03,1.59,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2W,285,9/2/03,1.38,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O38,285,9/2/03,1.38,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2V,285,9/2/03,1.5,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O37,285,9/2/03,1.45,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2U,285,9/2/03,1.41,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O36,298,9/2/03,1.7,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O2T,298,9/2/03,1.62,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O35,298,9/2/03,1.41,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3D,298,9/2/03,1.33,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3C,298,9/2/03,1.64,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3B,298,9/2/03,1.75,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1O3A,298,9/2/03,2,Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-Directed Serine Protease Inhibitors
1NT1,298,9/2/03,2,thrombin in complex with selective macrocyclic inhibitor
1NT0,100,5/20/03,2.7,Crystal structure of the CUB1-EGF-CUB2 region of MASP2
1O5G,285,9/21/04,1.75,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1NU7,100,10/7/03,2.2,Staphylocoagulase-Thrombin Complex
1O5F,285,9/21/04,1.78,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1O5E,285,9/21/04,1.75,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1O5D,113,9/21/04,2.05,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1O5C,285,9/21/04,1.63,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1O5B,285,9/21/04,1.85,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1O5A,285,9/21/04,1.68,Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)
1NU9,100,10/7/03,2.2,Staphylocoagulase-Prethrombin-2 complex
1O6G,100,11/18/02,1.4,"PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641N MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO"
1O6F,100,11/18/02,1.6,"PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, D641A MUTANT WITH BOUND PEPTIDE LIGAND SUC-GLY-PRO"
1O6E,100,11/14/02,2.3,Epstein-Barr virus protease
1NY2,298,3/4/03,2.3,Human alpha thrombin inhibited by RPPGF and hirugen
1NZQ,295,10/14/03,2.18,D-Phe-Pro-Arg-Type Thrombin Inhibitor
1NZI,100,6/10/03,1.5,Crystal Structure of the CUB1-EGF Interaction Domain of Complement Protease C1s
1OKE,100,7/24/03,2.4,Crystal structure of the dengue 2 virus envelope protein in complex with n-octyl-beta-D-glucoside
1OK8,100,1/29/04,2,Crystal structure of the dengue 2 virus envelope glycoprotein in the postfusion conformation
1OKX,100,10/24/03,2.8,Binding Structure of Elastase Inhibitor Scyptolin A
1OP0,298,5/25/04,2,"Crystal Structure of AaV-SP-I, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus"
1OOK,100,7/22/03,2.3,Crystal Structure of the Complex of Platelet Receptor GPIb-alpha and Human alpha-Thrombin
1OPH,100,8/5/03,2.3,NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
1OP8,100,7/1/03,2.5,Crystal Structure of Human Granzyme A
1P0S,100,8/26/03,2.8,Crystal Structure of Blood Coagulation Factor Xa in Complex with Ecotin M84R
1OP2,298,5/25/04,2.1,"Crystal Structure of AaV-SP-II, a Glycosylated Snake Venom Serine Proteinase from Agkistrodon acutus"
1P2J,100,4/20/04,1.35,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2I,100,4/20/04,1.65,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2Q,100,4/20/04,1.8,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2O,100,4/20/04,2,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2N,100,4/20/04,1.8,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2M,100,4/20/04,1.75,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1P2K,100,4/20/04,1.6,Structural consequences of accommodation of four non-cognate amino-acid residues in the S1 pocket of bovine trypsin and chymotrypsin
1ORF,100,7/1/03,2.4,The Oligomeric Structure of Human Granzyme A Reveals the Molecular Determinants of Substrate Specificity
1P3E,100,4/27/04,1.72,Structure of Glu endopeptidase in complex with MPD
1P3C,100,4/27/04,1.5,Glutamyl endopeptidase from Bacillus intermedius
1OT5,100,6/17/03,2.4,The 2.4 Angstrom Crystal Structure of Kex2 in complex with a peptidyl-boronic acid inhibitor
1OSS,100,8/19/03,1.93,T190P STREPTOMYCES GRISEUS TRYPSIN IN COMPLEX WITH BENZAMIDINE
1OS8,100,8/19/03,1.55,RECOMBINANT STREPTOMYCES GRISEUS TRYPSIN
1OS5,100,3/18/04,2.2,Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.
1P57,291,1/20/04,1.75,Extracellular domain of human hepsin
1OX1,291,5/18/04,2,crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor
1OWK,160,9/30/03,2.8,Substituted 2-Naphthamidine Inhibitors of Urokinase
1OWJ,160,9/30/03,3.1,Substituted 2-Naphthamidine Inhibitors of Urokinase
1P8J,100,7/8/03,2.6,CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN
1OWI,160,9/30/03,2.93,Substituted 2-Naphthamidine Inhibitors of Urokinase
1P8V,100,7/22/03,2.6,CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND ALPHA-THROMBIN AT 2.6A
1OAN,100,5/16/03,2.75,Crystal structure of the dengue 2 virus envelope protein
1OWH,160,9/30/03,1.61,Substituted 2-Naphthamidine Inhibitors of Urokinase
1OWE,160,9/30/03,1.6,Substituted 2-Naphthamidine inhibitors of urokinase
1OWD,160,9/30/03,2.32,Substituted 2-Naphthamidine inhibitors of urokinase
1OXG,278,5/18/04,2.2,Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution
1OYQ,100,4/29/03,1.9,TRYPSIN INHIBITOR COMPLEX
1OYO,298,5/20/03,2.02,Regulation of protease activity by melanin: Crystal structure of the complex formed between proteinase K and melanin monomers at 2.0 resolution
1OYV,100,7/15/03,2.5,Crystal structure of tomato inhibitor-II in a ternary complex with subtilisin Carlsberg
1OYT,100,6/24/03,1.67,COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR
1AB9,292,8/20/97,1.6,CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN
1AD8,277,11/12/97,2,COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY
1AF4,296,6/16/97,2.6,CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN ANHYDROUS DIOXANE
1AE8,298,12/3/97,2,HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP
1AFQ,292,9/17/97,1.8,CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR
1AFE,298,12/3/97,2,HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP
1AGJ,273,9/26/97,1.7,EPIDERMOLYTIC TOXIN A FROM STAPHYLOCOCCUS AUREUS
1AI8,100,10/15/97,1.85,HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROMPG
1AIX,100,10/15/97,2.1,HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL
1AK9,290,11/12/97,1.8,SUBTILISIN MUTANT 8321
8OHM,110,4/20/99,2.3,CRYSTAL STRUCTURE OF RNA HELICASE FROM GENOTYPE 1B HEPATITIS C VIRUS: MECHANISM OF UNWINDING DUPLEX RNA
8KME,293,3/24/99,2.1,CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770.
1AN1,294,7/1/98,2.03,LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX
1AMH,293,12/24/97,2.5,UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S)
1AO5,277,10/15/97,2.6,MOUSE GLANDULAR KALLIKREIN-13 (PRORENIN CONVERTING ENZYME)
1ANE,273,4/1/97,2.2,ANIONIC TRYPSIN WILD TYPE
1AND,273,4/1/97,2.3,ANIONIC TRYPSIN MUTANT WITH ARG 96 REPLACED BY HIS
1ANC,273,4/1/97,2.2,ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY LYS
1ANB,273,4/1/97,2.8,ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY GLU
1B12,100,12/10/99,1.95,CRYSTAL STRUCTURE OF TYPE 1 SIGNAL PEPTIDASE FROM ESCHERICHIA COLI IN COMPLEX WITH A BETA-LACTAM INHIBITOR
1B0F,287,11/9/98,3,"CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146"
1B0E,287,11/18/98,1.8,"CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146"
1B0L,293,11/18/99,2.2,RECOMBINANT HUMAN DIFERRIC LACTOFERRIN
1AQ7,93,2/25/98,2.2,TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B
1B1X,288,6/24/99,2.62,STRUCTURE OF DIFERRIC MARE LACTOFERRIN AT 2.62A RESOLUTION
1AQN,290,1/14/98,1.8,SUBTILISIN MUTANT 8324
1AT3,293,10/14/98,2.5,HERPES SIMPLEX VIRUS TYPE II PROTEASE
1AU9,290,12/31/97,1.8,SUBTILISIN BPN' MUTANT 8324 IN CITRATE
1AU8,293,10/14/98,1.9,HUMAN CATHEPSIN G
1B5G,273,5/27/98,2.07,HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1AV7,287,4/1/98,2.6,SUBTILISIN CARLSBERG L-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
1AUJ,273,10/14/98,2.1,BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR
1AUT,285,8/20/97,2.8,Human activated protein C
1B7Z,288,2/2/99,2.7,STRUCTURE OF OXALATE SUBSTITUTED DIFERRIC MARE LACTOFERRIN FROM COLOSTRUM
1AVX,283,10/28/98,1.9,"COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, TETRAGONAL CRYSTAL FORM"
1B7X,100,3/2/99,2.1,STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE
1AVW,293,10/28/98,1.75,"COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, ORTHORHOMBIC CRYSTAL FORM"
1AWF,290,10/28/98,2.2,NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1AVG,280,12/30/98,2.6,THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS
1B7U,100,2/2/99,3.8,Structure of Mare Apolactoferrin: the N and C Lobes are in the Closed Form
1AVT,287,3/25/98,2,SUBTILISIN CARLSBERG D-PARA-CHLOROPHENYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
1AWH,290,10/28/98,3,NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1AY9,277,1/28/98,3,WILD-TYPE UMUD' FROM E. COLI
1AY6,300,3/18/98,1.8,"THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF"
1AZ8,273,1/13/99,1.8,BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR
1AZZ,298,2/25/98,2.3,FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN
1BB0,300,4/27/99,2.1,THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1BA8,300,4/27/99,1.8,THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES
1BCU,293,10/14/98,2,ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN
1BDA,290,5/11/99,3.35,CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)
1BE8,296,10/28/98,2.2,TRANS-CINNAMOYL-SUBTILISIN IN WATER
1BE6,296,10/14/98,2.15,TRANS-CINNAMOYL-SUBTILISIN IN ANHYDROUS ACETONITRILE
1BFK,296,10/28/98,2.3,CRYSTAL STRUCTURE OF SUBTILISIN CARLSBERG IN 40% ACETONITRILE
1C2P,100,4/5/00,1.9,HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE
1BQY,293,8/20/99,2.5,Plasminogen activator (TSV-PA) from snake venom
1C2G,298,7/26/00,1.65,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2F,298,7/26/00,1.7,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2E,298,7/26/00,1.65,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2D,298,7/26/00,1.65,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2M,298,7/26/00,1.4,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2L,298,7/26/00,1.5,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2K,298,7/26/00,1.65,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2J,298,7/26/00,1.4,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2I,298,7/26/00,1.47,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C2H,298,7/26/00,1.4,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1BRU,287,8/25/99,2.3,STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783
1C3L,278,8/4/99,2.16,SUBTILISIN-CARLSBERG COMPLEXED WITH XENON (8 BAR)
1C4Y,300,10/9/00,2.7,SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS
1C4V,300,9/27/00,2.1,SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1C4U,300,9/27/00,2.1,SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1C5Z,298,12/22/00,1.85,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5Y,298,12/22/00,1.65,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5X,298,12/22/00,1.75,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5W,298,12/22/00,1.94,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5V,298,12/22/00,1.48,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1BTU,100,2/16/99,1.6,"PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4R)-1-TOLUENESULPHONYL-3-ETHYL-AZETIDIN-2-ONE-4-CARBOXYLIC ACID"
1C5U,298,12/22/00,1.37,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5T,298,12/22/00,1.37,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5S,298,12/22/00,1.36,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5R,298,12/22/00,1.47,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5Q,298,12/22/00,1.43,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5P,298,12/22/00,1.43,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5O,298,12/22/00,1.9,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5N,298,12/22/00,1.5,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5M,298,12/22/00,1.95,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1C5L,298,12/22/00,1.47,"STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR"
1BUI,190,9/2/99,2.65,Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-substrate complex in action
1C9T,277,8/3/00,3.3,COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN
1C9P,277,8/3/00,2.8,COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN
1BZX,293,11/11/98,2.1,THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1BH6,278,11/4/98,1.75,SUBTILISIN DY IN COMPLEX WITH THE SYNTHETIC INHIBITOR N-BENZYLOXYCARBONYL-ALA-PRO-PHE-CHLOROMETHYL KETONE
1BFU,296,10/28/98,2.2,SUBTILISIN CARLSBERG IN 20% DIOXANE
1BIO,95,6/22/99,1.5,HUMAN COMPLEMENT FACTOR D IN COMPLEX WITH ISATOIC ANHYDRIDE INHIBITOR
1BHX,293,11/4/98,2.3,X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357
1BJV,113,12/2/98,1.8,BETA-TRYPSIN COMPLEXED WITH APPU
1BJU,293,12/2/98,1.8,BETA-TRYPSIN COMPLEXED WITH ACPU
1BJR,288,11/4/98,2.44,COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K
1BIY,288,1/13/99,3.37,STRUCTURE OF DIFERRIC BUFFALO LACTOFERRIN
1BLF,298,12/3/97,2.8,STRUCTURE OF DIFERRIC BOVINE LACTOFERRIN AT 2.8 ANGSTROMS RESOLUTION
1BML,293,8/2/99,2.9,COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE
1BOQ,120,8/12/98,2.1,PRO REGION C-TERMINUS: PROTEASE ACTIVE SITE INTERACTIONS ARE CRITICAL IN CATALYZING THE FOLDING OF ALPHA-LYTIC PROTEASE
1C1V,298,7/26/00,1.98,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1U,298,7/26/00,1.75,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1T,298,7/26/00,1.37,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1S,298,7/26/00,1.63,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1R,298,7/26/00,1.37,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1Q,298,7/26/00,1.37,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1P,298,7/26/00,1.37,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1O,298,7/26/00,1.4,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1W,298,7/26/00,1.9,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1N,298,7/26/00,1.4,"RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES"
1C1M,277,7/28/99,2.2,PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR)
2H4I,298,6/13/06,2.55,Crystal structure of the complex of proteolytically produced C-terminal half of bovine lactoferrin with lactose at 2.55 A resolution
2H5D,100,9/26/06,0.9,"0.9A resolution crystal structure of alpha-lytic protease complexed with a transition state analogue, MeOSuc-Ala-Ala-Pro-Val boronic acid"
2H5C,100,9/26/06,0.82,0.82A resolution crystal structure of alpha-lytic protease at pH 5
2GVF,95,1/23/07,2.5,"HCV NS3-4A protease domain complexed with a macrocyclic ketoamide inhibitor, SCH419021"
2HCS,100,2/6/07,2.5,Crystal structure of RNA dependant RNA polymerase domain of West Nile virus
2HD4,298,7/4/06,2.15,Crystal structure of proteinase K inhibited by a lactoferrin octapeptide Gly-Asp-Glu-Gln-Gly-Glu-Asn-Lys at 2.15 A resolution
2HD0,93,8/1/06,2.28,Structure of the catalytic domain of hepatitis C virus NS2
2HCN,100,2/6/07,2.35,Crystal structure of RNA dependent RNA polymerase domain from west nile virus
2HFZ,100,2/6/07,3,Crystal structure of RNA dependent RNA polymerase domain from West Nile virus
2HLC,280,9/4/97,1.7,HL COLLAGENASE STRUCTURE AT 1.7A RESOLUTION
2I1R,100,10/31/06,2.2,"Novel Thiazolones as HCV NS5B Polymerase Inhibitors: Further Designs, Synthesis, SAR and X-ray Complex Structure"
2HPZ,298,8/1/06,1.69,Crystal structure of proteinase K complex with a synthetic peptide KLKLLVVIRLK at 1.69 A resolution
2I6S,100,10/17/06,2.7,Complement component C2a
2I6Q,100,10/17/06,2.1,Complement component C2a
2HVX,295,6/12/07,2.6,"Discovery of Potent, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase by Using Structure-Based Drug Design"
2I9A,100,11/28/06,1.9,Crystal structure of the free aminoterminal fragment of urokinase type plasminogen activator (ATF)
2HWH,100,11/7/06,2.3,HCV NS5B allosteric inhibitor complex
2HWL,148,9/19/06,2.4,Crystal structure of thrombin in complex with fibrinogen gamma' peptide
2HWI,100,11/7/06,2,HCV NS5B allosteric inhibitor complex
2I9B,100,1/2/07,2.8,Crystal structure of ATF-urokinase receptor complex
2ID4,100,5/1/07,1.9,The 1.9 A structure of Kex2 in complex with an Ac-R-E-R-K-chloromethyl ketone inhibitor.
2ID8,100,10/10/06,1.27,Crystal structure of Proteinase K
2IJO,170,5/15/07,2.3,Crystal Structure of the West Nile virus NS2B-NS3 protease complexed with bovine pancreatic trypsin inhibitor
2IJN,100,11/28/06,2.2,Isothiazoles as active-site inhibitors of HCV NS5B polymerase
2ILN,100,4/10/07,2,Crystal structure of the Bowman-Birk inhibitor from snail medic seeds in complex with bovine trypsin
2IOT,100,4/8/08,1.6,Clavulanic Acid bound to Elastase
2J38,100,9/27/06,2.1,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J2U,100,9/27/06,1.9,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J34,100,9/27/06,2.01,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2IRV,120,10/31/06,2.3,"Crystal structure of GlpG, a rhomboid intramembrane serine protease"
2J4U,100,2/13/07,2.99,E.coli OmpC - camel Lactoferrin complex
2J4I,100,9/27/06,1.8,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J7U,100,3/13/07,1.85,Dengue virus NS5 RNA dependent RNA polymerase domain
2J7W,100,3/13/07,2.6,Dengue virus NS5 RNA dependent RNA polymerase domain complexed with 3' dGTP
2J95,100,3/20/07,2.01,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J94,100,3/20/07,2.1,CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
6RUR,100,8/21/19,6,Structure of the SCIN stabilized C3bBb convertase bound to properdin
6RUV,100,8/21/19,6.15,Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1
6RUW,100,9/18/19,1.35,Zn-substituted alpha-Keggin bound to Proteinase K solved by MR
6RUK,100,9/18/19,1.2,Cu-substituted alpha-Keggin bound to Proteinase K solved by MR
6RUN,100,9/18/19,1.1,Co-substituted alpha-Keggin bound to Proteinase K solved by EP
6RUH,100,9/18/19,1.1,Ni-substituted alpha-Keggin bound to Proteinase K solved by MR
6RUG,100,9/18/19,1.1,Co-substituted alpha-Keggin bound to Proteinase K solved by MR
6RVE,100,9/18/19,1.15,Co-substituted beta-Keggin bound to Proteinase K solved by MR
6RVG,100,9/18/19,1.1,Co-substituted beta-Keggin bound to Proteinase K solved by MR
6S95,100,8/26/20,1.19,Crystal structure of group I of Usutu virus envelope protein domain III
6S94,100,8/26/20,1.79,Crystal structure of group D of Usutu virus envelope protein domain III
6RX7,100,7/8/20,1.63,Structure of the KIV type 2 (KIV-2) domain of lipoprotein (a)
6RWZ,100,7/15/20,1.7,Structure of Zika virus NS3 helicase in complex with ADP-BeF3
6S93,100,8/26/20,1.67,Crystal structure of group B of Usutu virus envelope protein domain III
6S92,100,8/26/20,1.93,Crystal structure of group A of Usutu virus envelope protein domain III
6S8C,100,5/20/20,2.57,Post-fusion conformation of the envelope protein of tick-borne encephalitis virus with longer stem
6RZP,293,7/17/19,2.2,Multicrystal structure of Proteinase K at room temperature using a multilayer monochromator.
6SF7,100,3/3/21,1.7,Atomic resolution structure of SplF protease from Staphylococcus aureus
6SHH,100,5/20/20,2,Human kallikrein 7 with aromatic coumarinic ester compound 1 covalently bound to H57
6SHI,100,5/20/20,1.85,Human kallikrein 7 with aromatic coumarinic ester compound 2 covalently bound to H57
6SI6,100,11/18/20,1.98,N-terminal domain of Drosophila X virus VP3
6SHW,100,11/18/20,2,N-terminal domain of Drosophila X Virus VP3
6SKC,100,9/25/19,2.18,Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3448330A
6SKB,100,9/25/19,1.84,Crystal Structure of Human Kallikrein 6 (N217D/I218Y/K224R) in complex with GSK3496783A
6SKD,100,9/25/19,2.26,Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK3397892A
6SJU,100,5/20/20,1.97,Human kallikrein 7 with aromatic coumarinic ester compound 3 covalently bound to H57
6SMA,100,4/8/20,2.59,Crystal structure of Human Neutrophil Elastase (HNE) in complex with the 3-Oxo-beta-Sultam inhibitor LMC249
6T0M,100,5/13/20,1.51,Cationic Trypsin in Complex with a D-Phe-Pro-diaminopyridine derivative
6T0P,100,5/13/20,1.19,Cationic Trypsin in Complex with a D-Phe-Pro-2-aminopyridine derivative
6TH7,100,3/4/20,2.2,Structure of porcine pancreatic elastase in complex with tutuilamide
6TKH,100,11/4/20,1.9,Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7keV
6TKG,100,11/4/20,1.35,Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12keV
6TKJ,100,11/4/20,2.81,Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7keV
6TKI,100,11/4/20,1.8,Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7keV
6TKL,100,11/4/20,1.3,Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin
6T3M,100,11/18/20,1.38,Thrombin in Complex with a D-Phe-Pro-p-phenol derivative
6T3Q,100,5/13/20,1.33,Thrombin in Complex with a D-Phe-Pro-2-aminopyridine derivative
6T52,100,11/18/20,1.45,Thrombin in Complex with a D-Phe-Pro-imidazole derivative
6T54,100,11/18/20,1.57,Thrombin in Complex with a D-Phe-Pro-2-bromothiophene Derivative
6T53,100,11/18/20,1.35,Thrombin in Complex with a D-Phe-Pro-p-benzylamine derivative
6T56,100,11/18/20,1.31,Thrombin in Complex with Benzylamine
6T55,100,11/18/20,1.39,Thrombin in Complex with Methylbenzylamine
6SSA,100,7/15/20,2.11,Human Leukocyte Antigen Class I A02 Carrying LLWNGPMQV
6T4A,100,5/13/20,1.31,Thrombin in Complex with a D-Phe-Pro-p-aminopyridine derivative
6SS7,100,7/15/20,2.5,Human Leukocyte Antigen Class I A02 Carrying LLWAGPMAV
6SS9,100,7/15/20,2.7,Human Leukocyte Antigen Class I A02 Carrying LLWNGPMHV
6SS8,100,7/15/20,2.24,Human Leukocyte Antigen Class I A02 Carrying LLWNGPIAV
6T57,100,11/18/20,1.57,Thrombin in Complex with a D-Phe-Pro-N-amidinopiperidine Derivative
6SV6,100,1/22/20,1.15,Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x38)
6SV8,100,1/22/20,1.15,Terahertz irradiated structure of bovine trypsin (odd frames of crystal x38)
6SV0,100,1/22/20,1.16,Non-terahertz irradiated structure of bovine trypsin (odd frames of crystal x37)
6T5W,100,5/13/20,1.13,Cationic Trypsin in Complex with a D-Phe-Pro-p-aminopyridine Derivative (cocrystallizaton at 291 K)
6SVR,100,1/22/20,1.16,Reference structure of bovine trypsin (odd frames of crystal x28)
6SVV,100,1/22/20,1.15,Reference structure of bovine trypsin (odd frames of crystal x30)
6SVU,100,1/22/20,1.15,Reference structure of bovine trypsin (even frames of crystal x30)
6SVX,100,1/22/20,1.16,Reference structure of bovine trypsin (odd frames of crystal x33)
6T89,100,11/18/20,2,"Thrombin in complex with (S)-N-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (MI-498)"
6SVW,100,1/22/20,1.16,Reference structure of bovine trypsin (even frames of crystal x33)
6SVJ,100,1/22/20,1.16,Terahertz irradiated structure of bovine trypsin (odd frames of crystal x42)
6SVI,100,1/22/20,1.16,Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x42)
6SVN,100,1/22/20,1.16,Reference structure of bovine trypsin (even frames of crystal x28)
6T7P,100,7/8/20,1.416,human plasmakallikrein protease domain in complex with active site directed inhibitor
6SW0,100,1/22/20,1.15,Reference structure of bovine trypsin (odd frames of crystal x34)
6SVB,100,1/22/20,1.15,Terahertz irradiated structure of bovine trypsin (odd frames of crystal x40)
6SVD,100,1/22/20,1.15,Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x41)
6T7H,100,9/30/20,2.32,Crystal structure of Thrombin in complex with macrocycle N14-PR4-A
6SVG,100,1/22/20,1.16,Terahertz irradiated structure of bovine trypsin (odd frames of crystal x41)
6SUX,100,1/22/20,1.16,Terahertz irradiated structure of bovine trypsin (even frames of crystal x37)
6SV9,100,1/22/20,1.15,Non-terahertz irradiated structure of bovine trypsin (even frames of crystal x40)
6T8U,100,3/4/20,2.84,"Complement factor B in complex with 5-Bromo-3-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-7-methyl-1H-indol-4-amine"
6T8W,100,3/4/20,1.7,"Complement factor B in complex with (-)-4-(1-((5,7-Dimethyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid"
6SWV,100,5/20/20,1.432,Trypsin fast data collection
6T8V,100,3/4/20,2.29,"Complement factor B in complex with (S)-5,7-Dimethyl-4-((2-phenylpiperidin-1-yl)methyl)-1H-indole"
6SVZ,100,1/22/20,1.15,Reference structure of bovine trypsin (even frames of crystal x34)
6T8A,100,11/18/20,1.62,Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((S)-1-((R)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (MI-492)
6T9T,100,11/18/20,1.69,"Matriptase in complex with the synthetic inhibitor (S)-3-(3-(4-(3-(tert-butyl)ureido)piperidin-1-yl)-2-((3'-fluoro-4'-(hydroxymethyl)-[1,1'-biphenyl])-3-sulfonamido)-3-oxopropyl)benzimidamide (MI-1904)"
6T9V,100,11/18/20,1.126427243,"Bovine Trypsin in complex with the synthetic inhibitor (S)-3-(3-(4-(3-(tert-butyl)ureido)piperidin-1-yl)-2-((3'-fluoro-4'-(hydroxymethyl)-[1,1'-biphenyl])-3-sulfonamido)-3-oxopropyl)benzimidamide (MI-1904)"
6T9U,100,11/18/20,1.06750905,"Bovine Trypsine in complex with the synthetic inhibitor (S)-3'-(N-(1-(4-(3-(tert-butyl)ureido)piperidin-1-yl)-3-(3-carbamimidoylphenyl)-1-oxopropan-2-yl)sulfamoyl)-[1,1'-biphenyl]-3-carboximidamide (MI-490)"
6SY3,100,5/13/20,0.95,Cationic Trypsin in Complex with a D-DiPhe-Pro-pyridine derivative
6SZW,100,7/22/20,3.14,Asymmetric complex of Factor XII and kininogen with gC1qR/C1QBP/P32 is governed by allostery
6TDT,100,5/13/20,1.53,Thrombin in Complex with a D-DiPhe-Pro-p-pyridine derivative
7DFT,100,5/19/21,1.8,Crystal structure of Xanthomonas oryzae ClpP
7DFU,100,5/19/21,1.901,Crystal structure of Xanthomonas oryzae ClpP S68Y in complex with ADEP4.
7DOC,100,4/14/21,1.904,Crystal structure of Zika NS2B-NS3 protease with compound 5
7CRA,80,5/26/21,1.7,Crystal structure of the N-terminal fragment (residue 1-291) of LonA protease from Meiothermus taiwanensis
7CR9,80,5/26/21,2.095,Crystal structure of the N-terminal fragment (residue 1-206) of LonA protease from Meiothermus taiwanensis
7D6M,100,12/23/20,1.894,Crystal structure of tick-borne encephalitis virus methyltransferase
7D6N,100,12/23/20,3.168,Crystal structure of tick-borne encephalitis virus RNA-dependent RNA polymerase
7JR1,100,7/21/21,2.05,Crystal structure of the R64F mutant of Bauhinia Bauhinioides Kallikrein Inhibitor complexed with Bovine Trypsin
7JR2,100,7/21/21,1.851,Crystal structure of the R64M mutant of Bauhinia Bauhinioides Kallikrein Inhibitor complexed with Bovine Trypsin
7JQN,100,7/21/21,1.5,Crystal structure of the R64M mutant of Bauhinia Bauhinioides Kallikrein Inhibitor complexed with Human Kallikrein 4
7JQO,100,7/21/21,1.6,Crystal structure of the R64D mutant of Bauhinia Bauhinioides Kallikrein Inhibitor complexed with Human Kallikrein 4
7JQK,100,7/21/21,1.33,Crystal structure of the R64A mutant of Bauhinia Bauhinioides Kallikrein Inhibitor complexed with Human Kallikrein 4
7JRX,100,7/21/21,1.77,Crystal structure of the R64F mutant of Bauhinia Bauhinioides complexed with Bovine Chymotrypsin
7JTQ,100,12/9/20,3.5,Human Complement Factor B Inhibited by a Slow Off-Rate Modified Aptamer of 31 Bases
7E6J,100,6/30/21,1.9,Aspartyl/Asparaginyl beta-hydroxylase (AspH) H725A in complex with Factor X peptide fragment (39mer-4Ser)
7DZD,100,7/14/21,2,Crystal structure of uPA in complex with cleaved camostat